PARK3 Influences Age at Onset in Parkinson Disease: A Genome Scan in the GenePD Study
β Scribed by Anita L. DeStefano; Mark F. Lew; Lawrence I. Golbe; Margery H. Mark; Alice M. Lazzarini; Mark Guttman; Erwin Montgomery; Cheryl H. Waters; Carlos Singer; Ray L. Watts; Lillian J. Currie; G. Frederick Wooten; Nancy E. Maher; Jemma B. Wilk; Kristin M. Sullivan; Karen M. Slater; Marie H. Saint-Hilaire; Robert G. Feldman; Oksana Suchowersky; Anne-Louise Lafontaine; Nancy Labelle; John H. Growdon; Peter Vieregge; Peter P. Pramstaller; Christine Klein; Jean P. Hubble; Carson R. Reider; Mark Stacy; Marcy E. MacDonald; James F. Gusella; Richard H. Myers
- Book ID
- 117853873
- Publisher
- American Society of Human Genetics
- Year
- 2002
- Tongue
- English
- Weight
- 354 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0002-9297
- DOI
- 10.1086/339814
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The ATP/ADP ratio reflects mitochondrial function and has been reported to be influenced by the size of the Huntington disease gene (__HD__) repeat. Impaired mitochondrial function has long been implicated in the pathogenesis of Parkinson's disease (PD), and therefore, we evaluated the
## Abstract We performed linkage analysis for age at onset (AAO) in the total Alzheimer's disease (AD) NIMH sample (Nβ=β437 families). Families were subset as lateβonset (320 families, AAO β₯65) and early/mixed (117 families, at least 1 member with 50< AAO <65). Treating AAO as a censored trait, we